Literature DB >> 24771073

CRP gene (1059G>C) polymorphism and its plasma levels in ischemic stroke and hemorrhagic stroke in a south Indian population.

Satrupa Das1, Sitara Roy, Subhash Kaul, Akka Jyothy, Anjana Munshi.   

Abstract

In the present study, we evaluated the association of 1059G>C polymorphism in C-reactive protein (CRP) gene with the risk of ischemic and hemorrhagic strokes. We did not find a significant association of this polymorphism with stroke. However, 2 % of mutants were observed in hemorrhagic stroke patients with a 0.01 frequency for the C allele. We also estimated the high-sensitivity C-reactive protein (hsCRP) levels in hemorrhagic stroke and compared the levels with our already published data on ischemic stroke. The hsCRP level in hemorrhagic stroke was found to be significantly elevated in comparison with that in controls (p<0.001). However, there was no difference in the mean value of hsCRP levels between types of stroke. In conclusion, the G>C polymorphism in the promoter region of the CRP gene is not abundant in the population and cannot be connected with different hsCRP levels and stroke prediction. The CRP level is a useful marker in stroke, but cannot help in differentiating between types of stroke.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24771073     DOI: 10.1007/s10753-014-9897-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  C-reactive protein and outcome after ischemic stroke.

Authors:  K W Muir; C J Weir; W Alwan; I B Squire; K R Lees
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

2.  Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype.

Authors:  Claes Ladenvall; Katarina Jood; Christian Blomstrand; Staffan Nilsson; Christina Jern; Per Ladenvall
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

3.  C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome.

Authors:  K Rajeshwar; Subhash Kaul; Amal Al-Hazzani; M Sai Babu; N Balakrishna; Vandana Sharma; A Jyothy; Anjana Munshi
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 4.  Role of C-reactive protein in cerebrovascular disease: a critical review.

Authors:  Mario Di Napoli; Mitchell S V Elkind; Daniel Agustin Godoy; Puneetpal Singh; Francesca Papa; Aurel Popa-Wagner
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-12

5.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

Review 6.  Human C-reactive protein: expression, structure, and function.

Authors:  J E Volanakis
Journal:  Mol Immunol       Date:  2001-08       Impact factor: 4.407

Review 7.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

Authors:  Valery L Feigin; Carlene M M Lawes; Derrick A Bennett; Craig S Anderson
Journal:  Lancet Neurol       Date:  2003-01       Impact factor: 44.182

8.  Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population.

Authors:  Anjana Munshi; Shehnaz Sultana; Subhash Kaul; B Pulla Reddy; Suvarna Alladi; A Jyothy
Journal:  J Neurol Sci       Date:  2008-06-30       Impact factor: 3.181

9.  Proinflammatory genetic profiles in subjects with history of ischemic stroke.

Authors:  Andrea Flex; Eleonora Gaetani; Pierangelo Papaleo; Giuseppe Straface; Anna S Proia; Giovanni Pecorini; Paolo Tondi; Paolo Pola; Roberto Pola
Journal:  Stroke       Date:  2004-08-12       Impact factor: 7.914

10.  Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

Authors:  Paolo Calabró; James T Willerson; Edward T H Yeh
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

View more
  6 in total

1.  C-Reactive Protein Gene Contributes to the Genetic Susceptibility of Hemorrhagic Stroke in Men: a Case-Control Study in Chinese Han Population.

Authors:  Yong Xue; Long Zhang; Yao Fan; Qianhui Li; Yuzhang Jiang; Chong Shen
Journal:  J Mol Neurosci       Date:  2017-07-18       Impact factor: 3.444

2.  Interaction Between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level.

Authors:  Duanxiu Liao; Xingyang Yi; Biao Zhang; Qiang Zhou; Jing Lin
Journal:  Genet Test Mol Biomarkers       Date:  2016-03-09

3.  Role of TLR4 (C1196T) and CD14 (C-260T) Polymorphisms in Development of Ischemic Stroke, Its Subtypes and Hemorrhagic Stroke.

Authors:  Satrupa Das; Subhash Kaul; Akka Jyothy; Anjana Munshi
Journal:  J Mol Neurosci       Date:  2017-09-30       Impact factor: 3.444

4.  Sanhuang Xiexin decoction promotes good functional outcome in acute ischemic stroke.

Authors:  Juexian Song; Xin Chen; Yi Lyu; Wei Zhuang; Jing Zhang; Li Gao; Xiaolin Tong
Journal:  Brain Behav       Date:  2018-12-19       Impact factor: 2.708

Review 5.  Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside.

Authors:  Mario Di Napoli; Mark Slevin; Aurel Popa-Wagner; Puneetpal Singh; Simona Lattanzi; Afshin A Divani
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

6.  Correlation Between Blood Glucose Variability and Early Therapeutic Effects After Intravenous Thrombolysis With Alteplase and Levels of Serum Inflammatory Factors in Patients With Acute Ischemic Stroke.

Authors:  Yun Cai; Hongtao Zhang; Qiang Li; Peilan Zhang
Journal:  Front Neurol       Date:  2022-02-22       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.